首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1520580

2024-2032 年靜脈曲張治療市場報告（按產品、程序、最終用戶和地區）

Varicose Vein Treatment Market Report by Product, Procedure, End User, and Region 2024-2032

出版日期: 2024年07月01日 | 出版商:

IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年，全球靜脈曲張治療市場規模達4.38億美元。老年人口的不斷成長、微創（MI）手術的技術進步、意識和醫療保健支出的提高，以及專注於創新和戰略合作以擴大治療選擇和地理覆蓋範圍的主要參與者是推動市場成長的一些因素。

靜脈曲張治療市場分析：

主要市場促進因素：由於老齡化人口中靜脈曲張盛行率的上升以及治療技術的進步，市場正在經歷適度成長。

主要市場趨勢：與傳統手術方法相比，由於微創治療方法療效顯著、疼痛減輕且恢復時間更短，人們正在轉向微創治療方法。除此之外，影像技術在靜脈曲張治療中的不斷整合，提高了治療和結果的精確度，也促進了市場的成長。

地理趨勢：由於高額醫療支出、先進的醫療基礎設施以及大眾對靜脈曲張疾病的認知不斷提高，北美在市場上佔據主導地位。

競爭格局：靜脈曲張治療產業的一些主要市場參與者包括 Alma Lasers Ltd. (Sisram Medical Ltd.)、Angiodynamics Inc.、Biolitec AG (BioMed Technology Holdings Ltd.)、Boston Scientific Corporation、Eufoton SRL、Fotona、 Medtronic plc 、Sciton Inc.、Teleflex Incorporated、The Vein Company、VVT Medical Ltd. 和WON TECH Co. Ltd. 等。

挑戰與機會：先進靜脈曲張治療的成本不斷增加，這對於沒有足夠保險覆蓋的患者來說可能令人望而卻步，特別是在低度開發地區，這正在影響市場收入。儘管如此，這也為行業參與者創造了開發負擔得起的解決方案的機會，從而增加了更廣泛人群獲得治療的機會。此外，獲得更多有關健康的知識是靜脈曲張治療市場最近的主要發展之一，可以告知潛在患者各種治療選擇，擴大潛在客戶群。

靜脈曲張治療市場趨勢：

治療技術進步

靜脈注射雷射治療 (EVLT)、射頻消融 (RFA) 和超音波導引硬化療法等不斷取得的進步正在改變治療方法，從侵入性手術轉向微創 (MI) 和非手術選擇。對於患者來說，此類新技術有望實現更快的恢復、更少的疼痛以及更少的術後併發症發生機會，這使得手術越來越受歡迎。 2023年，全球微創手術市場規模為529億美元。根據IMARC Group的報告，預計到 2032 年，市場規模將達到 910 億美元，2024-2032 年複合年成長率為 6%。雷射和射頻設備的進一步發展與成像技術相結合，可以對患病靜脈進行更精確的治療，從而推動了靜脈曲張治療的需求。公司正在將其收入用於研發（R＆D），以充分利用現有技術並提出新的創新。

醫療保健全球化

透過國際合作，醫療保健專業人員交流最佳實踐和技術，提高全球治療品質。例如，繼2023 年6 月獲得FDA 批准後，VVT Medical 宣布與Methapharm 達成策略性分銷協議，在美國銷售其ScleroSafe 平台。非熱、非-腫脹技術。這種全球性的交流保證了不同地區可以使用先進的治療技術和標準化的護理質量，支持靜脈曲張治療市場的成長。醫療旅遊也是一個因素，患者出國旅行以更實惠的價格尋求一流的治療。 2023年，全球醫療旅遊產業價值達1,197億美元。 IMARC Group估計，從2024 年到2032 年，市場將以20.1% 的複合年成長率擴張，到2032 年達到6508 億美元。和技術進步。

監管部門的批准和支持

獲得監管部門的批准和支持對於推動靜脈曲張治療的發展至關重要。監管機構為新的醫療器材和治療方法制定嚴格的標準並提供明確的核准程序。嚴格的監管環境促使公司投資研究和臨床試驗以推動創新。當局批准治療可以在醫療保健提供者和患者之間建立信任和信心，確保市場上有安全有效的選擇。此外，強力的監管可以加速尖端治療方法進入市場，加快其採用並擴大現代靜脈曲張治療選擇的範圍。 2024年4月，VVT Medical的ScleroSafe™設備獲得韓國食品藥物安全部的批准，在韓國市場實現了一個重要里程碑。這是在獲得 FDA 510(k) 許可和 CE 標誌之後，確認 ScleroSafe(TM) 是靜脈曲張治療的可靠選擇。

靜脈曲張治療市場細分：

IMARC Group對每個細分市場的主要靜脈曲張治療市場趨勢進行了分析，並對 2024-2032 年全球、區域和國家層面進行了預測。我們的報告根據產品、程序和最終用戶對市場進行了分類。

按產品分類：

消融裝置

射頻消融設備

雷射燒蝕裝置

其他

硬化劑注射

其他

該報告根據產品提供了詳細的市場細分和分析。這包括消融設備（射頻消融設備、雷射消融設備等）、硬化劑注射等。

消融設備是一個重要的部分，尤其是射頻和雷射消融設備，因為它們是治療靜脈曲張的首選。這些方法可以有效地封閉有問題的靜脈，其侵入性比迄今為止使用的方法要小，從而減輕疼痛並讓患者快速康復。射頻消融設備利用熱能來加熱和塌陷靜脈，而雷射消融則利用光能來實現類似的結果，為喜歡微創治療的患者提供了有效的選擇。 2023年，全球消融器械市場規模達59億美元。 IMARC Group預測，到 2032 年，該市值將達到 144 億美元，2024 年至 2032 年複合年成長率為 10.2%。

硬化劑注射劑在產業中佔有穩固的地位，進而影響靜脈曲張治療市場的收入。該技術包括將溶液注射到曲張靜脈中，導致疤痕並將血液重新引導到更健康的靜脈，最終導致治療後的靜脈消失。使用該技術是因為它可以有效地治療輕微靜脈曲張和蜘蛛網狀靜脈，並且易於使用且成本合理。它在門診環境中特別受歡迎，因為快速恢復是一個重要因素。

其他包括一系列額外的選擇，例如壓力襪和外科手術。壓力襪通常用作非手術方法來控制症狀並延緩靜脈曲張的進展，特別是在初始階段或輕度情況下。儘管由於微創 (MI) 技術的增加，現在較少使用外科手術，但在其他治療方法不起作用的嚴重情況下，仍會使用外科手術。該部分服務於廣泛的患者，提供從基本預防護理到廣泛手術治療的選擇。

依程序分解：

注射硬化療法

靜脈內消融

手術結紮和剝離

注射硬化療法佔業界最大佔有率

報告還提供了基於程序的詳細市場細分和分析。這包括注射硬化療法、靜脈內消融以及手術結紮和剝離。報告稱，注射硬化療法佔據最大的市場佔有率。

注射硬化療法是靜脈曲張治療產業中最主要的領域，主要是因為其有效性、低侵入性和成本效益。該過程包括將硬化劑溶液注射到曲張靜脈中，刺激靜脈壁，導致靜脈塌陷和黏合。隨著時間的推移，經過治療的靜脈會被周圍組織吸收，逐漸消失。硬化療法的受歡迎程度因其能夠在門診環境中進行、能夠快速解決美容問題以及小靜脈曲張和蜘蛛靜脈引起的不適以及恢復時間短而得到增強，使其成為既希望有效又方便的患者的首選。 2023年，全球硬化療法市場價值12億美元。 IMARC Group預計，從 2024 年到 2032 年，該市場將以 5.5% 的年複合成長率(CAGR) 擴張，到 2032 年將達到 20 億美元。

按最終用戶分類：

醫院

診所

門診中心

醫院代表領先的細分市場

該報告提供了基於最終用戶的詳細市場細分和分析。這包括醫院、診所和門診中心。報告稱，醫院佔最大部分。

醫院因其廣泛的治療選擇和處理需要先進醫療干預的複雜病例的能力而主導市場，塑造了積極的靜脈曲張治療市場前景。他們擁有提供各種類型靜脈曲張治療所需的基礎設施，包括硬化療法和靜脈內消融等侵入性較小的手術，以及手術結紮和剝離等更具侵略性的技術。對於正在尋求專業血管外科醫生和介入放射科醫生可靠且有效治療的患者來說，本部分將增強他們的信心。此外，醫院往往是晚期靜脈曲張患者的首選，這些患者可能需要各種醫療保健提供者的全面護理和長期監測，從而鞏固了其在市場中的地位。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美市場領先，佔據最大的靜脈曲張治療市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美是靜脈曲張治療的最大區域市場。

北美在市場上佔有最大佔有率，主要是由於大量的醫療保健支出、尖端的醫療技術和健全的醫療保健系統。該地區涵蓋美國和加拿大，由於老年居民中有大量靜脈曲張，因此對微創 (MI) 手術的需求很高。根據 2023 年美國人口普查局的報告，美國 65 歲及以上人口的數量預計將從 2022 年的 5800 萬增加到 2050 年的 8200 萬，成長 47%。 23%。此外，北美還擁有頂尖的醫療保健公司和鼓勵快速採用新技術的強大監管框架。該地區在全球市場上的強大影響力也得益於其廣泛的保險覆蓋範圍和高度的患者意識。

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。該行業的一些主要市場參與者包括 Alma Lasers Ltd. (Sisram Medical Ltd.)、Angiodynamics Inc.、Biolitec AG (BioMed Technology Holdings Ltd.)、Boston Scientific Corporation、Eufoton SRL、Fotona、Medtronic plc、Sciton Inc.。、 Teleflex Incorporated、The Vein Company、VVT Medical Ltd. 和WON TECH Co. Ltd.

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

市場主要參與者正在努力進行研發 (R&D)，以提高目前治療的效率和安全性，並尋求新解決方案的批准。領先的靜脈曲張治療公司正致力於透過建立策略合作夥伴關係、合併和收購其他公司來擴大其產品範圍，以加強其全球市場地位。例如，DXI Capital Corp.於2023年11月24日透露，計劃透過一份不具約束力的意向書收購VVT Med Ltd.和Exiteam Acquisition Corp.的全部股份。此舉旨在幫助 DXI 滿足 TSX Venture Exchange 的上市標準並維持 VVT 的靜脈曲張治療業務。此外，也大力關注行銷和教育活動，以提高醫療保健提供者和患者對靜脈曲張治療進展的認知。這些措施的重點是促進現代和侵入性較小的療法的使用，擴大市場上的治療選擇。

靜脈曲張治療市場新聞：

2023 年 9 月：FDA 批准了 VVT Medical 的 ScleroSafe 平台，用於在不使用熱或腫脹方法的情況下治療淺靜脈曲張。該小工具已在多個領域獲得批准，可使用具有反向作用的雙注射器同時管理和清除物質。

本報告回答的關鍵問題：

迄今為止，全球靜脈曲張治療市場表現如何，未來幾年將如何表現？
全球市場的促進因素、限制因素和靜脈曲張治療市場近期的機會是什麼？
每個促進因素、限制因素和機會對全球市場有何影響？
主要區域市場有哪些？
哪些國家代表了最具吸引力的市場？
基於產品的市場區隔是什麼？
市場上最有吸引力的產品是什麼？
市場分類的程序是什麼？
市場上最有吸引力的程序是什麼？
基於最終用戶的市場區隔是什麼？
哪個是市場上最具吸引力的最終用戶？
市場競爭結構如何？
誰是全球靜脈曲張治療市場的主要參與者/公司？

本報告回答的關鍵問題：

迄今為止，全球靜脈曲張治療市場表現如何，未來幾年將如何表現？
全球市場的促進因素、限制因素和靜脈曲張治療市場近期的機會是什麼？
每個促進因素、限制因素和機會對全球市場有何影響？
主要區域市場有哪些？
哪些國家代表了最具吸引力的市場？
基於產品的市場區隔是什麼？
市場上最有吸引力的產品是什麼？
市場分類的程序是什麼？
市場上最有吸引力的程序是什麼？
基於最終用戶的市場區隔是什麼？
哪個是市場上最具吸引力的最終用戶？
市場競爭結構如何？
誰是全球靜脈曲張治療市場的主要參與者/公司？

市場結構
關鍵參與者
關鍵參與者簡介
- Alma Lasers Ltd. (Sisram Medical Ltd.)
- Angiodynamics Inc.
- Biolitec AG (BioMed Technology Holdings Ltd.)
- Boston Scientific Corporation
- Eufoton SRL
- Fotona
- Medtronic plc
- Sciton Inc.
- Teleflex Incorporated
- The Vein Company
- VVT Medical Ltd.
- WON TECH Co. Ltd

簡介目錄圖表

Product Code: SR112024A5494

The global varicose vein treatment market size reached US$ 438.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 670.8 Million by 2032, exhibiting a growth rate (CAGR) of 4.8% during 2024-2032. The growing elderly population, technological advancements in minimally invasive (MI) procedures, increasing awareness and healthcare spending, and key players focusing on innovation and strategic collaborations to expand treatment options and geographic reach are some of the factors impelling the market growth.

Varicose Vein Treatment Market Analysis:

Major Market Drivers: The market is experiencing moderate growth because of the rising prevalence of varicose veins among the aging population and advancements in treatment technologies.

Key Market Trends: There is a shift towards less invasive treatment methods because of their efficacy, reduced pain, and shorter recovery periods compared to traditional surgical methods. Besides this, the growing integration of imaging technologies in varicose vein treatments, which enhances the precision of treatments and outcomes, is contributing to the growth of the market.

Geographical Trends: North America dominates the market, driven by high healthcare expenditure, advanced medical infrastructure, and increasing awareness about varicose vein conditions among the masses.

Competitive Landscape: Some of the major market players in the varicose vein treatment industry include Alma Lasers Ltd. (Sisram Medical Ltd.), Angiodynamics Inc., Biolitec AG (BioMed Technology Holdings Ltd.), Boston Scientific Corporation, Eufoton S.R.L., Fotona, Medtronic plc, Sciton Inc., Teleflex Incorporated, The Vein Company, VVT Medical Ltd. and WON TECH Co. Ltd., among many others.

Challenges and Opportunities: The growing cost of advanced varicose vein treatments, which can be prohibitive for patients without adequate insurance coverage, particularly in less developed regions, is influencing the market revenue. Nevertheless, this also creates a chance for industry participants to develop affordable solutions that can increase the availability of treatments to a wider range of people. Moreover, gaining more knowledge about health presents one of the major varicose vein treatment market recent developments to inform potential patients about the various treatment options, broadening the potential customer base.

Varicose Vein Treatment Market Trends:

Technological Advancements in Treatment

Ongoing advancements like endovenous laser therapy (EVLT), radiofrequency ablation (RFA), and ultrasound-guided sclerotherapy are changing treatment approaches from invasive surgeries to minimally invasive (MI) and non-surgical options. For patients, such new technologies promise quicker recovery, less pain, and smaller chances of post-operation complications, which is causing the popularity of the surgeries to grow. In 2023, the size of the global minimally invasive surgery market was US$ 52.9 Billion. As per the report by the IMARC Group, the market is expected to reach US$ 91.0 Billion by 2032, exhibiting a CAGR of 6% during 2024-2032. Further development of lasers and radiofrequency devices in combination with imaging technologies for more pinpoint treatment in the ailing veins is driving the varicose vein treatment demand. Companies are channelizing their revenues for research and development (R&D) to make the best use of technologies existing and to come up with new innovations.

Globalization of Healthcare

By partnering internationally, healthcare professionals exchange best practices and technologies, enhancing the quality of treatment globally. For instance, VVT Medical announced a strategic distribution agreement with Methapharm to market its ScleroSafe platform in the USA, following FDA approval in June 2023. This collaboration leverages Methapharm's expertise in varicose veins, aiming to transform treatment with ScleroSafe's innovative, non-thermal, non-tumescent technique. This worldwide exchange guarantees that advanced treatment techniques are available in different areas with standardization of care quality, supporting the varicose vein treatment market growth. Medical tourism is also a factor, with patients traveling overseas in search of top-notch treatments at more affordable prices. In 2023, the medical tourism industry in the world was valued at US$119.7 billion. The IMARC Group estimates the market would expand at a CAGR of 20.1% from 2024 to 2032, reaching US$ 650.8 billion in 2032. Globalization leads to increased accessibility and improved quality of varicose vein treatments worldwide, supporting market expansion and technological progress.

Regulatory Approvals and Support

Obtaining regulatory approvals and support is essential for advancing the development of varicose vein treatment. Regulatory agencies establish stringent criteria and provide clear approval procedures for new medical devices and treatments. The strict regulatory landscape motivates companies to invest in research and clinical trials to drive innovation. The approval of treatments by authorities builds trust and confidence between healthcare providers and patients, guaranteeing the presence of secure and efficient choices in the market. Furthermore, robust regulations can accelerate the entry of cutting-edge treatments into the market, quickening their adoption and expanding the range of modern options for varicose vein treatment. In April 2024, VVT Medical achieved a major milestone in the Korean market with the approval of its ScleroSafe(TM) device by the Korean Ministry of Food and Drug Safety. This was after the FDA 510(k) clearance and CE Mark, confirming ScleroSafe(TM) as a dependable option for varicose vein treatment.

Varicose Vein Treatment Market Segmentation:

IMARC Group provides an analysis of the key varicose vein treatment market trends in each segment, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, procedure, and end user.

Breakup by Product:

Ablation Devices

Radiofrequency Ablation Devices

Laser Ablation Devices

Others

Sclerotherapy Injection

Others

The report has provided a detailed breakup and analysis of the market based on the product. This includes ablation devices (radiofrequency ablation devices, laser ablation devices, and others), sclerotherapy injection, and others.

Ablation devices are an important segment, especially radiofrequency and laser ablation devices, because they are preferred in the treatment of varicose veins. These are effective in shutting off problematic veins with ways that are less invasive than those used hitherto, thereby inflicting less pain and delivering the patient to recovery quickly. Radiofrequency ablation devices utilize thermal energy to heat and collapse the vein, while laser ablation uses light energy to accomplish similar outcomes, providing effective options for patients who prefer less invasive treatments. In 2023, the market size of ablation devices worldwide reached US$ 5.9 billion. IMARC Group forecasts that the market will reach a value of US$ 14.4 billion by 2032, showing a 10.2% CAGR from 2024 to 2032.

Sclerotherapy injections have a solid presence in the industry, thereby influencing the varicose vein treatment market revenue. This technique includes injecting a solution into the varicose veins, which results in scarring and redirecting blood to healthier veins, ultimately causing the treated vein to vanish. The technique is used because of its effectiveness in addressing minor varicose veins and spider veins, its ease of use, and its reasonable cost. It is particularly popular in outpatient settings, where fast recovery is an important factor.

Others encompass a range of additional options, such as compression stockings and surgical procedures. Compression stockings are often utilized as a non-surgical method to control symptoms and delay the advancement of varicose veins, especially in the initial phases or mild instances. Surgical procedures, while less frequently used now because of the increase in minimally invasive (MI) techniques, are still utilized in serious situations when other treatments do not work. This part serves a wide range of patients, providing options from basic preventive care to extensive surgical treatments.

Breakup by Procedure:

Injection Sclerotherapy

Endovenous Ablation

Surgical Ligation and Stripping

Injection sclerotherapy holds the largest share of the industry

A detailed breakup and analysis of the market based on the procedure have also been provided in the report. This includes injection sclerotherapy, endovenous ablation, and surgical ligation and stripping. According to the report, injection sclerotherapy accounted for the largest market share.

Injection sclerotherapy is the most dominant sector in the varicose vein treatment industry, mainly because of its effectiveness, low level of invasiveness, and cost-effectiveness. The process includes injecting a sclerosant solution into the varicose veins to irritate the vein walls, leading them to collapse and bond. As time passes, the vein that has been treated fades away as it gets absorbed back into the surrounding tissue. The popularity of sclerotherapy is enhanced by its ability to be performed in outpatient settings, its quick resolution of cosmetic concerns and discomfort from small varicose and spider veins, and its short recovery time, making it a preferred option for patients wanting both effectiveness and convenience. In 2023, the sclerotherapy market in the world was valued at US$ 1.2 billion. The IMARC Group projects that the market will expand at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2032, when it reaches US$ 2.0 billion in 2032.

Breakup by End User:

Hospitals

Clinics

Ambulatory Centers

Hospitals represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, clinics, and ambulatory centers. According to the report, hospitals represented the largest segment.

Hospitals dominate the market due to their extensive treatment options and ability to manage complicated cases that require advanced medical interventions, shaping a positive varicose vein treatment market outlook. They have the required infrastructure to offer various types of treatments for varicose veins, including less invasive procedures like sclerotherapy and endovenous ablation and more aggressive techniques such as surgical ligation and stripping. This section benefits a strong level of confidence from patients who are looking for dependable and efficient treatments from specialized vascular surgeons and interventional radiologists. Moreover, hospitals play a key role in are frequently the top choice for patients with advanced varicose veins who may need comprehensive care from various healthcare providers and extended monitoring, solidifying their position in the market.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest varicose vein treatment market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for varicose vein treatment.

North America holds biggest share in the market, mainly due to substantial healthcare expenditure, cutting-edge medical technologies, and a solid healthcare system. This area, encompassing both the United States and Canada, shows a high need for minimally invasive (MI) procedures because of a high number of varicose veins in its elderly residents. As per the 2023 US Census Bureau report, the number of people in the US aged 65 and above was projected to increase by 47% from 58 million in 2022 to 82 million by 2050. Furthermore, it is expected that the percentage of people in this age range in the overall population will rise from 17% to 23%. Furthermore, North America is advantaged by having top healthcare firms and a strong regulatory framework that encourages quick uptake of new technologies. The strong presence of the region in the global market is also influenced by its extensive insurance coverage and high level of patient consciousness.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the industry include Alma Lasers Ltd. (Sisram Medical Ltd.), Angiodynamics Inc., Biolitec AG (BioMed Technology Holdings Ltd.), Boston Scientific Corporation, Eufoton S.R.L., Fotona, Medtronic plc, Sciton Inc., Teleflex Incorporated, The Vein Company, VVT Medical Ltd. and WON TECH Co. Ltd.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key players in the market are working diligently on research and development (R&D) to improve the efficiency and safety of current treatments, as well as pursuing approval for new solutions. Leading varicose vein treatment companies are concentrating on broadening their range of products by forming strategic partnerships, merging, and acquiring other companies to strengthen their global market position. For example, DXI Capital Corp. revealed on November 24, 2023, its plan to acquire the entirety of V.V.T. Med Ltd. and Exiteam Acquisition Corp. through a non-binding letter of intent. This move was made to help DXI fulfill TSX Venture Exchange's listing criteria and sustain VVT's varicose vein treatment operations. Furthermore, there is a strong focus on marketing and educational initiatives to increase awareness about the progress in varicose vein treatments among both healthcare providers and patients. These initiatives focus on promoting the use of modern and less intrusive therapies, expanding the range of treatment choices in the market.

Varicose Vein Treatment Market News:

September 2023: The FDA approved ScleroSafe platform by VVT Medical for treating superficial varicose veins without using heat or tumescent methods. This gadget, approved in various areas, administers and removes substances at the same time using a dual syringe with a reverse action.

Key Questions Answered in This Report:

How has the global varicose vein treatment market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and varicose vein treatment market recent opportunities in the global market?
What is the impact of each driver, restraint, and opportunity on the global market?
What are the key regional markets?
Which countries represent the most attractive market?
What is the breakup of the market based on the product?
Which is the most attractive product in the market?
What is the breakup of the market based on the procedure?
Which is the most attractive procedure in the market?
What is the breakup of the market based on the end user?
Which is the most attractive end user in the market?
What is the competitive structure of the market?
Who are the key players/companies in the global varicose vein treatment market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Varicose Vein Treatment Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Ablation Devices
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Radiofrequency Ablation Devices
  - 6.1.2.2 Laser Ablation Devices
  - 6.1.2.3 Others
- 6.1.3 Market Forecast
6.2 Sclerotherapy Injection
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Others
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Procedure

7.1 Injection Sclerotherapy
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Endovenous Ablation
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Surgical Ligation and Stripping
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by End User

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Ambulatory Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Alma Lasers Ltd. (Sisram Medical Ltd.)
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
- 14.3.2 Angiodynamics Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Biolitec AG (BioMed Technology Holdings Ltd.)
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
- 14.3.4 Boston Scientific Corporation
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Eufoton S.R.L.
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 Fotona
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
- 14.3.7 Medtronic plc
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Sciton Inc.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
- 14.3.9 Teleflex Incorporated
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 The Vein Company
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
- 14.3.11 VVT Medical Ltd.
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
- 14.3.12 WON TECH Co. Ltd
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
  - 14.3.12.3 Financials

簡介目錄圖表

List of Figures

Figure 1: Global: Varicose Vein Treatment Market: Major Drivers and Challenges
Figure 2: Global: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: Global: Varicose Vein Treatment Market: Breakup by Product (in %), 2023
Figure 5: Global: Varicose Vein Treatment Market: Breakup by Procedure (in %), 2023
Figure 6: Global: Varicose Vein Treatment Market: Breakup by End User (in %), 2023
Figure 7: Global: Varicose Vein Treatment Market: Breakup by Region (in %), 2023
Figure 8: Global: Varicose Vein Treatment (Ablation Devices) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Varicose Vein Treatment (Ablation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Varicose Vein Treatment (Sclerotherapy Injection) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Varicose Vein Treatment (Sclerotherapy Injection) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Varicose Vein Treatment (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Varicose Vein Treatment (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Varicose Vein Treatment (Injection Sclerotherapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Varicose Vein Treatment (Injection Sclerotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Varicose Vein Treatment (Endovenous Ablation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Varicose Vein Treatment (Endovenous Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Varicose Vein Treatment (Surgical Ligation and Stripping) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Varicose Vein Treatment (Surgical Ligation and Stripping) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Varicose Vein Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Varicose Vein Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Varicose Vein Treatment (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Varicose Vein Treatment (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Varicose Vein Treatment (Ambulatory Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Varicose Vein Treatment (Ambulatory Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: North America: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: North America: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: United States: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: United States: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Canada: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Canada: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Asia-Pacific: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Asia-Pacific: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: China: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: China: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Japan: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Japan: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: India: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: India: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: South Korea: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: South Korea: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Australia: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Australia: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Indonesia: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Indonesia: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Others: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Others: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Europe: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Europe: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Germany: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Germany: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: France: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: France: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: United Kingdom: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: United Kingdom: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Italy: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Italy: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Spain: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Spain: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Russia: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Russia: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Others: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Others: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Latin America: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Latin America: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Brazil: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Brazil: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Mexico: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Mexico: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Others: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Others: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Middle East and Africa: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Middle East and Africa: Varicose Vein Treatment Market: Breakup by Country (in %), 2023
Figure 74: Middle East and Africa: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Global: Varicose Vein Treatment Industry: SWOT Analysis
Figure 76: Global: Varicose Vein Treatment Industry: Value Chain Analysis
Figure 77: Global: Varicose Vein Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Varicose Vein Treatment Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Varicose Vein Treatment Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Varicose Vein Treatment Market Forecast: Breakup by Procedure (in Million US$), 2024-2032
Table 4: Global: Varicose Vein Treatment Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Varicose Vein Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Varicose Vein Treatment Market: Competitive Structure
Table 7: Global: Varicose Vein Treatment Market: Key Players

02-2729-4219

+886-2-2729-4219